TY - JOUR
T1 - The loss of antibody productivity in continuous culture of hybridoma cells
AU - Frame, Kelly K.
AU - Hu, Wei-Shou
PY - 1990/3/5
Y1 - 1990/3/5
N2 - Two hybridoma lines, HB8178 and AFP‐27, were grown in continuous culture. The concentrations of viable cells as well as those of various nutrients and metabolites reached steady‐state values. The concentrations of either total IgG or antigen‐specific antibody, however, failed to reach steady‐state values but rather continuously decreased over the course of the cultures. The fraction of antibody‐producing cells in the total cellular population also continuously decreased in the AFP‐27 cultures. Comparison of the specific antibody productivity based on either the entire population or the antibody‐producing fraction of the population over time suggests that the decrease in productivity was at least partly due to the occurrence of a nonproducing subpopulation of cells.
AB - Two hybridoma lines, HB8178 and AFP‐27, were grown in continuous culture. The concentrations of viable cells as well as those of various nutrients and metabolites reached steady‐state values. The concentrations of either total IgG or antigen‐specific antibody, however, failed to reach steady‐state values but rather continuously decreased over the course of the cultures. The fraction of antibody‐producing cells in the total cellular population also continuously decreased in the AFP‐27 cultures. Comparison of the specific antibody productivity based on either the entire population or the antibody‐producing fraction of the population over time suggests that the decrease in productivity was at least partly due to the occurrence of a nonproducing subpopulation of cells.
UR - http://www.scopus.com/inward/record.url?scp=0025700415&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025700415&partnerID=8YFLogxK
U2 - 10.1002/bit.260350504
DO - 10.1002/bit.260350504
M3 - Article
C2 - 18592539
AN - SCOPUS:0025700415
SN - 0006-3592
VL - 35
SP - 469
EP - 476
JO - Biotechnology and bioengineering
JF - Biotechnology and bioengineering
IS - 5
ER -